TipRanks
Go Ultimate55% OFF

Coheris (COH) Stock Price & Analysis

1 Followers

COH Stock Chart & Stats

€7.98-€0.16(-1.97%)
At close: 5:30 PM GMT+1
€8€9€10€11Aug 10Aug 24Sep 7Sep 21Oct 7Oct 19Nov 2
Day’s Range
EUR 7.98 - EUR 8.16
52-Week Range
EUR 7.54 - EUR 15.45
Previous Close
EUR 8.14
Volume
N/A
Average Volume (3M)
1,588
Market Cap
EUR 46.28M
Enterprise Value
EUR 74.38M
Total Cash (Recent Filing)
EUR 72.00K
Total Debt (Recent Filing)
EUR 3.38M
Price to Earnings (P/E)
15.1
Beta
0.48
Next Earnings
Apr 22, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
1.00%

Bulls Say, Bears Say

Bulls Say

Steady Revenue And Profitability

Coheris has combined several years of revenue growth with sustained profitability after its 2020 loss. This demonstrates an established ability to monetize its software activities and provides an earnings base that can support continued investment and operating resilience over the next several quarters.

Debt-Free Balance Sheet

The elimination of debt materially reduces financial risk and recurring financing obligations. Growing equity gives Coheris greater flexibility to fund product development, absorb operating variability, or pursue commercial opportunities without relying heavily on external borrowing.

Positive Free Cash Flow

Consistently positive operating and free cash flow indicates that the business is generating internal funding rather than depending solely on accounting earnings or new financing. Stronger 2025 free cash flow can support reinvestment and improve financial flexibility over the medium term.

Bears Say

Gross Margin Volatility

The sharp variation in gross margin makes the durability of Coheris's earnings less certain. If the lower margin level persists, revenue growth may translate into weaker operating profit, while further mix or cost changes could make medium-term performance harder to predict.

Weak Cash Conversion

Although cash generation is positive, operating cash flow has generally been modest relative to reported profits. This weaker conversion can limit the amount of earnings readily available for reinvestment or distributions and raises the importance of sustaining the recent free cash flow improvement.

Declining EPS

Negative EPS growth indicates that per-share earnings have weakened despite the company's broader profitability and revenue progress. If this trend continues, it could signal pressure on earnings quality or shareholder-level earnings momentum and reduce the benefit of future top-line expansion.

Coheris News

COH FAQ

What was Coheris’s price range in the past 12 months?
Coheris lowest stock price was €7.54 and its highest was €15.45 in the past 12 months.
What is Coheris’s market cap?
Coheris’s market cap is €46.28M.
When is Coheris’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Coheris’s earnings last quarter?
Coheris released its earnings results on Sep 30, 2026. The company reported €0.32 earnings per share for the quarter.
Is Coheris overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Coheris pay dividends?
Coheris pays a Annually dividend of €0.08 which represents an annual dividend yield of 1%. See more information on Coheris dividends here
What is Coheris’s EPS estimate?
Coheris’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Coheris have?
Coheris has 5,685,575 shares outstanding.
What happened to Coheris’s price movement after its last earnings report?
Coheris reported an EPS of €0.32 in its last earnings report. Following the earnings report the stock price went up 2.093%.
Which hedge fund is a major shareholder of Coheris?
Currently, no hedge funds are holding shares in FR:COH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology